The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and ...
9d
Medpage Today on MSNStudies Point to Several Options for Ulcerative Colitis After Anti-TNF FailureSAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness ...
Johnson & Johnson (JNJ) said on Friday that its late-stage study of TREMFYA as an induction therapy for adults with ...
Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Palisade Bio presented a poster titled “PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug, Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS Mouse Model” at the Crohn’s & Colitis Congress ...
Proctitis affects the rectum, whereas ulcerative colitis can affect the colon, the rectum, or both parts of the intestine. Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD ...
Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according to the ...
Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...
Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients ...
A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results